ALISHA COURTNEY: Open Payments
NPI 1457081408 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 37 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $726
Food & beverage: $721Education: $6
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $210 |
| Novo Nordisk Inc | 5 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| ABBVIE INC. | 2 | $40 |
| Seqirus USA Inc | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: FARXIGA, AIRSUPRA, JARDIANCE, Rybelsus, VRAYLAR, TRELEGY ELLIPTA, Fluad, Kerendia.
Industry payments across AZ — which companies pay providers there.
